Related Experiment Video
Updated: May 1, 2026

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
Published on: November 2, 2013
Transcription factor ERG is a specific and sensitive diagnostic marker for hepatic angiosarcoma
Zhan-Bo Wang1, Jing Yuan1, Wei Chen1
1Zhan-Bo Wang, Jing Yuan, Wei Chen, Li-Xin Wei, Department of Pathology, Chinese People's Liberation Army General Hospital, Beijing 100853, China.
ERG is a highly sensitive and specific marker for diagnosing hepatic angiosarcoma. This study found ERG expression in all hepatic angiosarcoma samples, outperforming other markers like CD31 and CD34.
Area of Science:
- Oncology
- Pathology
- Immunohistochemistry
Background:
- Hepatic angiosarcoma (HAS) is a rare and aggressive liver cancer.
- Accurate diagnosis is crucial for patient management and prognosis.
- Limited understanding of specific diagnostic markers for HAS.
Purpose of the Study:
- To evaluate the diagnostic utility of ERG, CD34, CD31, and FVIIIRAg in hepatic angiosarcoma.
- To compare the sensitivity and specificity of these markers for HAS diagnosis.
Main Methods:
- Analysis of 24 hepatic angiosarcoma (HAS) samples using immunohistochemistry.
- Evaluation of ERG, CD34, CD31 (PECAM-1), and FVIIIRAg expression.
- Comparison of marker expression in HAS versus non-HAS tumors.
Main Results:
- ERG was expressed in 100% of HAS samples.
- CD31 (79.2%), CD34 (87.5%), and FVIIIRAg (41.7%) showed variable expression.
- This cohort represents the largest published HAS case series.
Conclusions:
- ERG is a more sensitive and specific marker for diagnosing hepatic angiosarcoma.
- ERG can aid in differentiating HAS from other liver tumors.
More Related Videos
Related Concept Videos
Regulation of Angiogenesis and Blood Supply
General Transcription Factors
Transcription Factors
Master Transcription Regulators
lncRNA - Long Non-coding RNAs

